The Pharma Data

SEPTEMBER 8, 2021

Adds Rezurock™ (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy. Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc.

FDA Approval 52

FDA Approval Therapies Small Molecule FDA 52

Advarra

AUGUST 16, 2022

A rare, or orphan, disease by definition affects a small percentage of the population — fewer than 200,000 people in the U.S. Food and Drug Administration (FDA) approval. Since then, the FDA has significantly changed its approach to rare and orphan diseases. The FDA Since 1983.

Disease 52

Disease Clinical Trials FDA Approval FDA 52

Drug Target Review

OCTOBER 17, 2024

This year we completed investigational new drug (IND) enabling studies of ONC-841, which is an antagonist of Siglec-10, and received US Food and Drug Administration (FDA) approval for first-in-human study (FIH) in patients with solid tumours. The first patient has been dosed in the last quarter.

Immune Response 52

Immune Response Clinical Trials Trials Therapies 52

The Pharma Data

JANUARY 27, 2021

Our objective is to work with Bruker and our clinical partners to deliver an effective and high throughput assay protocol, that can be applied in the clinical setting, with the required sensitivity and specificity and CE/FDA approvals to provide a useful additional diagnostic tool in the fight against the coronavirus.

Laboratories 52

Laboratories FDA Approval Hospitals Regulations 52

sptlabtech

JUNE 27, 2022

Farruk Kabir | NGS Lab Manager | Aperture NextGen Laboratories Aperture NextGen Laboratories is an FDA approved CLIA lab for interdisciplinary clinical testing and research. We can do that, and it's definitely a good idea."

Laboratories 52

Laboratories FDA Approval RNA FDA 52

Vial

JUNE 12, 2024

Role of PROs in drug approvals A recent review sought to comprehensively characterize the inclusion of PROs and regulatory considerations in FDA-approved novel oncology drugs. Such complications may otherwise be missed if only disease-specific PROs are used.

Clinical Trials 52

Clinical Trials Trials FDA Clinical Research 52

Agency IQ

NOVEMBER 3, 2023

So what about all of the “biotic” terms that pop up in the news, on products labels and even in FDA warning letters? Unfortunately, there is no regulatory body that governs the terminology used in this space, although there are definitions that are generally accepted by the scientific community.

Therapies 40

Therapies Science FDA Production 40

The Pharma Data

JUNE 26, 2021

The European Commission (EC) has approved Sanofi and Regeneron’s PD-1 inhibitor Libtayo ® (cemiplimab) for the first-line treatment of adults with non-small cell lung cancer (NSCLC) whose tumor cells have ?50% Patients must have metastatic NSCLC or locally advanced NSCLC and not be a candidate for definitive chemoradiation.

Treatment 52

Treatment Trials Disease FDA Approval 52

Agency IQ

JUNE 7, 2024

Dietary supplements are intended for ingestion only, meaning that products that are administered through other routes, such as topically, by injection or by inhalation, do not fall within this definition. L-glutamine offers an example of a more recently approved drug product. One longstanding example is the laxative senna.

FDA 40

FDA Science Production FDA Approval 40

The ChEMBL-og

APRIL 16, 2024

The definition of a chemical probe has been amended to update the field MOLECULE_DICTIONARY.CHEMICAL_PROBE.

Clinical Trials 108

Clinical Trials FDA Cell Based Assays Compound Screening 108

The Premier Consulting Blog

OCTOBER 11, 2022

The treatment had been granted breakthrough therapy designation, but FDA approval would ultimately rest on the sponsor’s ability to demonstrate clinically meaningful improvement.

Disease 52

Disease FDA FDA Approval Treatment 52

The Pharma Data

OCTOBER 27, 2021

Kymriah was preliminarily granted orphan medicinal product designation by the European Commission (EC) forFL.However, Kymriah would have the occasion to present an important treatment option for those cases with r/ r FL in need of potentially definitive issues, If approved in this implicit third suggestion.

FDA 52

FDA Treatment Trials FDA Approval 52

Advarra

JANUARY 23, 2024

FDA approval of a new drug for the condition under study) Impact of participation on alternative therapies (e.g., IRB Review of Minor Study Changes Federal regulations and guidance do not provide a singular definition for “minor” changes to research. a data breach) Decrease in expected benefits to participation (e.g.,

Research 52

Research Therapies FDA Approval Regulations 52

Agency IQ

MAY 17, 2024

Following FDA approval, these products are granted seven years of marketing exclusivity, preventing FDA from approving the “same drug for the same disease or condition” if the applicant does not have the right to reference the product (i.e., DORIS MATSUI (D-Calif.) and GUS BILIRAKIS (R-Fla.), TAMMY BALDWIN (D-Wisc.).

FDA 40

FDA Disease FDA Approval Production 40

PPD

AUGUST 5, 2024

Food and Drug Administration (FDA)-approved therapies for treating PAH were primarily vasodilators, designed to overcome the imbalance between vasoactive and vasodilator mediators and to restore endothelial cell function. Their early definition — as well as plans for recording and tracking — is a major factor in a trial’s success.

Clinical Trials 98

Clinical Trials Trials Clinical Research Disease 98

Agency IQ

JULY 8, 2024

One of these major changes was the addition of an entirely new section on medical gases to the Food, Drug, and Cosmetic (FD&C) Act, including a new definition of medical gases as drugs that are “manufactured or stored in a liquefied, nonliquefied, or cryogenic state” and are administered as a gas.

FDA 40

FDA Regulations Production Packaging 40

The Pharma Data

OCTOBER 22, 2020

With today’s FDA approval, and regulatory approvals or temporary authorizations in approximately 50 additional countries around the world, Veklury® (remdesivir) is one of the tools available today. [ii] Related Articles: Veklury (remdesivir) FDA Approval History. Published online on October 8, 2020.

Science 52

Science Clinical Trials Hospitals Trials 52

Practical Cheminformatics

FEBRUARY 1, 2023

As of 2021, there are over 70 FDA-approved drugs that are kinase inhibitors. Some examples of FDA-approved kinase inhibitors include imatinib (Gleevec), dasatinib (Sprycel), and lapatinib (Tykerb). While this can provide a small degree of confidence, it's far from definitive.

FDA Approval 52

FDA Approval FDA Drugs Science 52

Agency IQ

MAY 31, 2024

For this reason, the guidance advises sponsors that “some technologies that industry and FDA have historically considered to be platform technologies might not meet the statutory definition and statutory eligibility factors and, if not, would not be eligible for the designation program.”

Science 40

Science FDA Production Licensing 40

Eye on FDA

APRIL 15, 2020

But a new drug launch in the time of COVID-19 comes with definite challenges. Bristol Myers Squibb stated in its press release announcing FDA approval of the company’s treatment for multiple sclerosis that the commercial launch would be delayed due to the COVID-19 situation. Recently in the U.S.

Therapies 55

Therapies Treatment FDA Approval Laboratories 55

The Pharma Data

JULY 8, 2021

1%] as determined by an FDA-approved test, with no EGFR or ALK genomic tumor aberrations, and is stage III where patients are not candidates for surgical resection or definitive chemoradiation, or metastatic. 1%) as determined by an FDA-approved test, with disease progression on or after platinum-containing chemotherapy.

FDA Approval 52

FDA Approval FDA Treatment Therapies 52

Codon

JULY 14, 2024

While blood doesn’t fit neatly into the various definitions of an organ , it still comprises a discrete system with specific functions. Despite the initial promise of PFCs and FDA approval of a product called Fluosol-DA in 1989, PFCs have many drawbacks.

Production 131

Production Clinical Trials Trials Therapies 131

Advarra

JULY 19, 2022

The sponsor-initiated IND is conducted by a pharma company seeking commercial approval. Q: When you want to do a study of an FDA-approved drug under an investigational indication, is an IND still required or can you seek an exemption? Q: What is the definition of a drug? A: It depends, but the answer is usually yes.

Packaging 52

Packaging FDA Trials Regulations 52

Agency IQ

APRIL 26, 2024

The draft guidance provided language stating that all products, whether biosimilar or interchangeable, be referred to as “biosimilar” on the product label, with a general definition explaining the term biosimilar. Today, FDA published a revised version of the Q&A guidance on promotional labeling. Yes, the guidance confirms.

Biosimilars 40

Biosimilars Science FDA Licensing 40

The Pharma Data

JANUARY 22, 2021

Food and Drug Administration (FDA) approved the use of Aurinia Pharmaceuticals’ Lupkynis TM (voclosporin) as the first oral treatment developed specifically for adults with active lupus nephritis (LN) in combination with standard of care. NEW YORK , Jan. Lupus Research Alliance President and CEO Kenneth M.

Research 52

Research Treatment FDA Approval Disease 52

The Pharma Data

OCTOBER 23, 2020

Remdesivir gets full FDA approval to treat COVID. Remdesivir’s full approval Thursday by the FDA comes after the agency granted it emergency use authorization last spring. CDC widens definition of ‘close contact’ for tracking COVID infections. It is given intravenously to hospitalized patients.

Hospitals 52

Hospitals Virus FDA Government 52

Agency IQ

JUNE 2, 2023

Curiously, there is no direction for the patient to seek out the full FDA-approved labeling. Information included in the PMI : FDA intends that the PMI would “highlight the most important information that patients need to know to help them use their prescription drug products safely and effectively.”

FDA 40

FDA FDA Approval Production Regulations 40

Agency IQ

SEPTEMBER 22, 2023

Heckler in 1986, several manufacturers sued the FDA after it ordered them to remove several indications from the labels of their oral proteolytic enzymes (OPE) products for lack of evidence. The Heckler case helped to refine the definition of “substantial evidence” in two important ways.

FDA 40

FDA Science Trials Clinical Trials 40

Agency IQ

NOVEMBER 10, 2023

Cosmetics must also be in compliance with the Fair Packaging and Labeling Act ( FP&L Act ); however, only color additives require FDA approval before they may be used in cosmetics.

Production 40

Production FDA Compliance Packaging 40

The Pharma Data

OCTOBER 24, 2020

Remdesivir gets full FDA approval to treat COVID-19. Remdesivir’s full approval Thursday by the U.S. The FDA also has given emergency authorization to using the blood plasma of survivors, and two companies are seeking emergency authorization for experimental antibody drugs.

Hospitals 52

Hospitals Virus FDA Government 52

Molecular Design

OCTOBER 14, 2018

An 'unofficial' definition for the term PAINS has actually been published and I think that it's pretty good: "PAINS, or pan-assay interference compounds, are compounds that have been observed to show activity in multiple types of assays by interfering with the assay readout rather than through specific compound/target interactions."

Screening Hits 52

Screening Hits FDA Approval Drugs FDA 52

Agency IQ

OCTOBER 6, 2023

If a drug was previously approved for cancer, but is now approved for a cardiology condition, it would not be considered novel. The FDA also refers to novel products as “New Molecular Entities,” or NMEs. Data on these novel approvals is published throughout the year by both CDER and CBER. of all NME approvals this year.

FDA 52

FDA Biosimilars Science Production 52

The Pharma Data

APRIL 27, 2021

Changes in net sales are expressed at constant exchange rates (CER) unless otherwise indicated (definition in Appendix 7) (1) In order to facilitate an understanding of operational performance, Sanofi comments on the business net income statement. Business net income is a non-GAAP financial measure (definition in Appendix 7).

Vaccine 52

Vaccine Production FDA Disease 52

The Pharma Data

JANUARY 20, 2021

Approximately 1 in 10 people living with ILD cannot be given a definitive diagnosis, even after a thorough investigation, and in these cases, they are categorized as having unclassifiable interstitial lung disease (UILD). Esbriet was FDA-approved for use in people with IPF in October 2014. About the Pivotal Study. About Esbriet.

FDA 52

FDA Disease Doctors Treatment 52

The Pharma Data

DECEMBER 17, 2020

These follow-on data provided the first definitive prospective evidence demonstrating anti-viral activity for a treatment regimen now available for COVID-19, and also further documented the ability of this treatment to decrease the need for further medical attention,” said George D. Have chronic kidney disease. Have diabetes.

Hospitals 52

Hospitals Production Clinical Trials Therapies 52

The Pharma Data

NOVEMBER 20, 2020

Casirivimab and imdevimab injection is an investigational combination therapy and has been authorized by FDA for the emergency use described above. Casirivimab and imdevimab injection is not FDA approved for any use. Definition of High-Risk Patients. REGN-COV2 (casirivimab and imdevimab) FDA Approval History.

Therapies 52

Therapies FDA Clinical Trials Hospitals 52

The Pharma Data

JANUARY 9, 2021

See “Reconciliation of Non-GAAP Measures” for a definition of the terms and reconciliation tables.). 1) See “Reconciliation of Non-GAAP Measures” for a definition of terms and applicable reconciliation tables. The Company’s definition of these non-GAAP measures may differ from similarly titled measures used by others.

Government 52

Government Vaccine Production Licensing 52